Andere Kunden interessierten sich auch für
![Preventive, Diagnostic and Therapeutic Strategies for Abdominal Surgery Complications]( "Preventive, Diagnostic and Therapeutic Strategies for Abdominal Surgery Complications")
Preventive, Diagnostic and Therapeutic Strategies for Abdominal Surgery Complications68,99 €![Therapeutic Strategies for Modulating the Inflammatory Diseases]( "Therapeutic Strategies for Modulating the Inflammatory Diseases")
Therapeutic Strategies for Modulating the Inflammatory Diseases39,99 €![Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine]( "Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine")
Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine78,99 €![Cardiovascular Risk Factors and Intervention Strategies for the Prevention of Cardiovascular Disease]( "Cardiovascular Risk Factors and Intervention Strategies for the Prevention of Cardiovascular Disease")
Cardiovascular Risk Factors and Intervention Strategies for the Prevention of Cardiovascular Disease68,99 €![Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approches in Non Communicable Diseases]( "Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approches in Non Communicable Diseases")
Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approches in Non Communicable Diseases80,99 €![Shifting the Therapeutic Paradigm for Children with Neuromotor Disabilities to Maximizing Development]( "Shifting the Therapeutic Paradigm for Children with Neuromotor Disabilities to Maximizing Development")
Shifting the Therapeutic Paradigm for Children with Neuromotor Disabilities to Maximizing Development83,99 €![New Strategies for Treatment of Sepsis]( "New Strategies for Treatment of Sepsis")
New Strategies for Treatment of Sepsis49,99 €
The eight publications in this Special Issue focus on advancing therapeutic strategies specifically tailored to pediatric patients. Despite addressing a wide range of conditions (including fungal infections, cancer, spinal muscular atrophy, sleep-disordered breathing, and drug-induced cardiotoxicity), they share a common goal: to improve the safety, efficacy, and personalization of pediatric therapies. Several studies highlight the importance of appropriate dosing, formulation stability, and bioavailability (e.g., fluconazole, AmBisome®, and temozolomide), emphasizing the challenges of adapting adult medications for children and the need for age-specific drug testing to minimize the risks associated with off-label prescribing. Gene therapy and precision medicine also emerge as key themes, showcasing innovative therapeutic approaches. Finally, the Special Issue reflects a clear shift toward patient-centered care, promoting safer drug delivery, improved monitoring (e.g., through cardiotoxicity biomarkers), and more evidence-based treatment protocols for children. Collectively, these studies underscore the critical need to design and validate pediatric therapies based on the unique physiological and developmental characteristics of this population.